優(yōu)化流程縮短DNT課件_第1頁
優(yōu)化流程縮短DNT課件_第2頁
優(yōu)化流程縮短DNT課件_第3頁
優(yōu)化流程縮短DNT課件_第4頁
優(yōu)化流程縮短DNT課件_第5頁
已閱讀5頁,還剩24頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

1、優(yōu)化流程縮 短 DNT 武漢市第一醫(yī)院神經(jīng)內(nèi)科 2016年4月16日靜脈溶栓2015DNT時(shí)間控制不良預(yù)后因素優(yōu)化流程問題及改進(jìn)相關(guān)研究目錄靜脈溶栓2015醫(yī)院(排名不分先后)例數(shù)DNT市一醫(yī)院8065省人民醫(yī)院5470陸軍總醫(yī)院2372天佑醫(yī)院2073市三醫(yī)院1275漢口醫(yī)院475長航、市四、市五、漢陽、武昌醫(yī)院11889一六一醫(yī)院885東西湖醫(yī)院695144%105%市一醫(yī)院年份201320142015靜脈rt-PA溶栓治療例數(shù)163980靜脈溶栓2015靜脈溶栓、橋接治療、血管內(nèi)治療10人70人5人7人市一醫(yī)院靜脈溶栓2015DNT 80min 9例分析 ,多在檢驗(yàn)環(huán)節(jié)耽誤DNT時(shí)間控制

2、月份(N=27)9月10月11月12月單月均DNT(min)90796371累月均DNT(min)90837365 9-12月平均縮短DNT25min,目前DNT為65minDNT時(shí)間控制優(yōu)化流程急性卒中綠色通道路徑圖優(yōu)化流程急性缺血性腦卒中靜脈溶栓治療方案 急性缺血性腦卒中血管內(nèi)治療方案優(yōu)化流程問題及改進(jìn)總結(jié)分析DNT達(dá)標(biāo)及延誤原因,改進(jìn)流程在排除相關(guān)病史用藥史后,AIS靜脈溶栓前不等待血小板和凝血功能指標(biāo)聯(lián)合其他優(yōu)化措施,可顯著縮短DNT,不增加slCH和7d內(nèi)的死亡風(fēng)險(xiǎn)。減少檢驗(yàn)延誤楊璐萌 程忻 凌倚峰 等. 急性缺血性卒中靜脈溶栓前是否需等待血小板計(jì)數(shù)和凝血功能指標(biāo) ,中華神經(jīng)科雜志2

3、014,47(7):464-468Gottesman RF,Ah J,Wityk RJ,et a1Predicting abnormalcoagulation in ischemic stroke:reducing delay in rtPA useJNeurology,2006,67:16651667問題及改進(jìn)減少患者入院后延誤:急診醫(yī)生陪同減少電梯延誤:提前通知電梯等候減少病房延誤:門口平車上評(píng)估、查體后談話(靜脈、橋接)簽字,病人安頓、監(jiān)護(hù)好后即可開始給藥治療NIHSS評(píng)分6分以上備皮、導(dǎo)尿、通知介入小組每月召開總結(jié)會(huì),反饋DNT時(shí)間、討論改進(jìn)辦法問題及改進(jìn)Patients should

4、 receive endovascular therapy with a stent retriever if they meet all the following criteria (Class I; Level of Evidence A). (New recommendation): (a) prestroke mRS score 0 to 1, (b) acute ischemic stroke receiving intravenous r-tPA within 4.5 hours of onset according to guidelines from professional

5、 medical societies, (c) causative occlusion of the internal carotid artery or proximal MCA (M1), (d) age 18 years, (e) NIHSS score of 6, (f) ASPECTS of 6, and (g) treatment can be initiated (groin puncture) within 6 hours of symptom onset 橋接治療的納入標(biāo)準(zhǔn)AHA/ASA Guideline:2015 AHA/ASA Focused Update of the

6、 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment. Downloaded from / at Pfizer DIS on July 2, 2015問題及改進(jìn)Saver JL. Stroke. 2006 Jan;37(1):263-6.大血管、幕上缺血性卒中神經(jīng)回路損失的預(yù)估速度神經(jīng)元丟失突觸丟失有髓纖維丟失加速老化每次卒中12億8.3萬億7140千米36年每小時(shí)1.2億8300億714千米3.6年每分鐘190萬140億

7、12千米3.1周每秒鐘32,0002.3億200米8.7小時(shí)相關(guān)研究分小時(shí)天炎癥梗死周圍去極化興奮性中毒細(xì)胞凋亡時(shí)間影響The benefits of intravenous tPA in acute ischemic stroke are highly time-dependent.Because of the importance of rapid treatment, AHA/ASA guidelines recommend a door-to-needle (DTN) time of 60 minutes.Yet prior studies suggested fewer than 3

8、0% of intravenous tPA treated acute ischemic stroke patients in the United States were meeting this goal.To address this shortfall, Target: Stroke, a national initiative organized by the AHA/ASA, was launched in January 2010 to increase the proportion of stroke patients with DTN times 60 minutes (in

9、itial goal of 50%).Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative. ISC 2014, LB12 相關(guān)研究Improving Door-to-Needle Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative. ISC 2014, LB12相關(guān)研究Improving Door-to-Need

10、le Times in Acute Ischemic Stroke: Principal Results from the Target: Stroke Initiative. ISC 2014, LB12Target: Stroke 10 Key Best Practice Strategies1.Hospital pre-notification by Emergency Medical Services2.Rapid triage protocol and stroke team notification3.Single call/paging activation system for

11、 entire stroke team4.Use of a stroke toolkit containing clinical decision support, stroke-specific order sets, guidelines, hospital-specific algorithms, critical pathways, NIH Stroke Scale and other stroke tools5.Rapid acquisition and interpretation of brain imaging6.Rapid Laboratory Testing (includ

12、ing point-of-care testing) if indicated7.Pre-mixing tPAmedication ahead of time for high likelihood candidates8.Rapid access to intravenous tPAin the ED/brain imaging area9.Team-based approach10.Rapid data feedback to stroke team on each patients DTN time and other performance data相關(guān)研究一項(xiàng)來自美國Target:S

13、troke項(xiàng)目共304家醫(yī)院5460例接受tPA治療患者的研究,旨在評(píng)估醫(yī)院策略和縮短DNT時(shí)間的相關(guān)性在11項(xiàng)縮短DNT的醫(yī)院策略中,快速分診并通知卒中小組(平均縮短8.1分鐘),卒中小組集合(縮短4.3分鐘)以及急診儲(chǔ)備tPA(縮短3.5分鐘)是最有效的三種方法??焖俜衷\并通知卒中小組卒中小組集合急診儲(chǔ)備tPA縮短8.1min縮短4.3min縮短3.5min62%使用率P=0.0363%使用率P=0.01869%使用率P=0.008 Xian Y, et al. Strategies Used by Hospitals to Improve Speed of Tissue-Type Pla

14、sminogen Activator Treatment in Acute Ischemic troke.Stroke. 2014;45:1387-1395相關(guān)研究共71,169例接受rt-PA的患者,其中項(xiàng)目開展前為27,319例,開展后為43,850例DNT60min患者比例在項(xiàng)目開展前為29.6%,項(xiàng)目開展后增加到53.3%。開展前后的年增加率為1.36%vs.6.20%,P0.001臨床預(yù)后指標(biāo)得到改善!OutcomePre-Target: Stroke(n=27,319)Post-Target: Stroke(n=43,850)Difference Pre and PostP Val

15、ue院內(nèi)死亡率9.93%8.25%-1.68%P值*出院回家37.6%42.7%+5.1%0.0001獨(dú)立行動(dòng)能力42.2%45.4%+3.2%0.0001癥狀性出血5.68%4.68%-1.00%0.0001tPA相關(guān)并發(fā)癥6.68%5.50%-1.18%0.0001DNT60分比例(%) Fonarow GC, et al. JAMA. 2014 Apr 23-30;311(16):1632-40.相關(guān)研究While there have been concerns that attempting to achieve shorter DTN times may lead to rushe

16、d assessments, inappropriate patient selection, dosing errors, and greater likelihood of complications, our findings suggest that more rapid reperfusion therapy in acute ischemic stroke is not only feasible, but can be achieved with actual reductions in complications and improved outcomes.These findings further reinforce the importance and substantial clinical benefits of more rapid administration of intravenous tPA.Fonarow GC et al. JAMA. 2014;311(16):1632-1640.Conclusions相關(guān)研究入院到溶栓治療時(shí)間60分鐘到達(dá)急診的疑似卒中患者醫(yī)師初始評(píng)估(包括病史,實(shí)驗(yàn)

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論